Tenaya Therapeutics (TNYA) Other Working Capital Changes (2020 - 2026)

Tenaya Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $10.4 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 1592.4% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 2204.99% increase from a year earlier, with the FY2025 full-year figure at -$2.8 million, changed N/A from the prior year.
• Other Working Capital Changes climbed to $10.4 million in Q1 2026 per TNYA's latest filing, from -$697000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $10.4 million in Q1 2026 and bottomed at -$3.1 million in Q4 2022.
• The 5-year median for Other Working Capital Changes is -$697000.0 (2025), against an average of $265764.7.
• Across the five-year window, Other Working Capital Changes plunged 379.82% in 2022 and soared 1592.4% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$3.1 million in 2022, then jumped by 197.95% to $3.1 million in 2023, then climbed by 4.32% to $3.2 million in 2024, then plunged by 121.86% to -$697000.0 in 2025, then surged by 1592.4% to $10.4 million in 2026.
• Per Business Quant, the three latest TNYA Other Working Capital Changes figures stand at $10.4 million (Q1 2026), -$697000.0 (Q4 2025), and -$683000.0 (Q3 2025).